
New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.
Badrinath R. Konety, MD, is the assistant professor, department of urology, University of Iowa, and chief of the urology service, VA Medical Center, Iowa City.

New bladder cancer data are food for thought, but are not conclusive proof that urologists are over-treating early-stage bladder cancer and running up costs.

The value and timing of chemotherapy in patients undergoing cystectomy for clinically localized bladder cancer has long been controversial. There are myriad reasons supporting both neoadjuvant and adjuvant chemotherapies.

Published: August 1st 2009 | Updated:

Published: November 1st 2008 | Updated: